TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33566149

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 360

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Center-involving DME at baseline in the fellow eye
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Older subject age
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Higher baseline study eye ETDRS score
Number of subjects: 360
Study: 32458286

Group type: EXPERIMENTAL
Intervention: Right lateral decubitus starting position
Number of subjects: 185

Group type: COMPARATOR
Intervention: Left lateral decubitus starting position
Number of subjects: 185
Study: 34195866

Group type: EXPERIMENTAL
Intervention: Hot + normobaric hypoxic (HH)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxic (HYP)
Number of subjects: 11
Study: 35160235

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 30 min sessions, 2 sessions per day for 5 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 39
Study: 34842135

Group type: EXPERIMENTAL
Intervention: Antidepressant continuation (maintenance group)
Number of subjects: 478

Group type: COMPARATOR
Intervention: Antidepressant discontinuation (discontinuation group)
Number of subjects: 478
Study: 34918163

Group type: EXPERIMENTAL
Intervention: Coping with stress
Number of subjects: 39
Study: 32776493

Group type: EXPERIMENTAL
Intervention: High-volume low-intensity resistance exercise (HV-LRE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise (HRE)
Number of subjects: 22
Study: 34244118

Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Laparoscopic Prostatectomy (RALP)
Number of subjects: 348
Study: 33215550

Group type: EXPERIMENTAL
Intervention: STVQT before ventricular arrhythmia
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: STVQT in nonsustained ventricular arrhythmia
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: STVQT in nonsustained ventricular tachycardia
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: STVQT in sustained ventricular tachycardia
Number of subjects: 2331

Group type: COMPARATOR
Intervention: STVQT in control group
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Comparison of STVQT increase in sustained vs nonsustained ventricular arrhythmia
Number of subjects: 2331
Study: 34666507

Group type: EXPERIMENTAL
Intervention: First-line aspiration
Number of subjects: 205

Group type: COMPARATOR
Intervention: Stent retriever thrombectomy
Number of subjects: 205
Study: 33902334

Group type: EXPERIMENTAL
Intervention: Tai Chi/Qigong (TCQ)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Preferred program
Number of subjects: 13
Study: 34008144

Group type: EXPERIMENTAL
Intervention: Rilonacept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colchicine and nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0
Study: 34654487

Group type: EXPERIMENTAL
Intervention: Peer-mentoring intervention
Number of subjects: 276
Study: 33107460

Group type: EXPERIMENTAL
Intervention: Mtwo R
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: D‐RaCe
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProTaper R
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: R‐Endo
Number of subjects: 60
Study: 34185584

Group type: EXPERIMENTAL
Intervention: Eplerenone treatment
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 32293822

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic screening
Number of subjects: 0
Study: 33992567

Group type: EXPERIMENTAL
Intervention: Carillon device
Number of subjects: 95

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 95
Study: 35727392

Group type: COMPARATOR
Intervention: RIPC alone
Number of subjects: 185

Group type: COMPARATOR
Intervention: Nitrates alone
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: RIPC + Nitrates
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Nitrates + RIPC
Number of subjects: 185
Study: 32892655

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg tablet (formulation 1)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg tablet (formulation 2)
Number of subjects: 31
Study: 33818398

Group type: EXPERIMENTAL
Intervention: T1 (husband invitation, standard counseling)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: T2 (no husband invitation, targeted counseling)
Number of subjects: 782

Group type: EXPERIMENTAL
Intervention: T3 (husband invitation, targeted counseling)
Number of subjects: 782

Group type: COMPARATOR
Intervention: T0 (no husband invitation, standard counseling)
Number of subjects: 782
Study: 32246251

Group type: EXPERIMENTAL
Intervention: Fingolimod (FTY)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Teriflunomide (TERI)
Number of subjects: 629
Study: 32008386

Group type: EXPERIMENTAL
Intervention: Uterine exteriorization
Number of subjects: 95

Group type: COMPARATOR
Intervention: Intraperitoneal uterine repair
Number of subjects: 95
Study: 33802917

Group type: EXPERIMENTAL
Intervention: Food for Special Medical Purposes (FSMP) consisting of arginine, glutamine and HMB for 4 weeks
Number of subjects: 0
Study: 32629738

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 120
Study: 35667420

Group type: EXPERIMENTAL
Intervention: Surgery with intrauterine instillation of hyaluronic acid gel
Number of subjects: 343

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Surgery with hyaluronic acid gel
Number of subjects: 343
Study: 35881310

Group type: EXPERIMENTAL
Intervention: Synchronized tele-exercise (SG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 33753542

Group type: EXPERIMENTAL
Intervention: Higher-Calorie Refeeding (HCR) - 2000 kcals per day, increasing by 200 kcals per day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower-Calorie Refeeding (LCR) - 1400 kcals per day, increasing by 200 kcals every other day
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Higher-Calorie Refeeding (HCR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower-Calorie Refeeding (LCR)
Number of subjects: 120
Study: 33922802

Group type: EXPERIMENTAL
Intervention: Protein-rich, low-glycaemic meal replacement
Number of subjects: 463

Group type: COMPARATOR
Intervention: Lifestyle intervention alone
Number of subjects: 463
Study: 35565117

Group type: EXPERIMENTAL
Intervention: Capacitive and Resistive Electric Transfer (CRet) intervention
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 33507834

Group type: EXPERIMENTAL
Intervention: Palliative care provision
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Palliative service
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Palliative care group
Number of subjects: 2800
Study: 36375455

Group type: EXPERIMENTAL
Intervention: Food vouchers
Number of subjects: 774

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 774
Study: 33709117

Group type: EXPERIMENTAL
Intervention: EMDR
Number of subjects: 74

Group type: COMPARATOR
Intervention: CAU
Number of subjects: 74
Study: 35972817

Group type: EXPERIMENTAL
Intervention: Ribociclib (400 mg) combined with weekly carboplatin and paclitaxel chemotherapy followed by ribociclib maintenance
Number of subjects: 35
Study: 33709375

Group type: EXPERIMENTAL
Intervention: NGS-based preimplantation genetic testing for aneuploidy (PGT-A) of trophectoderm biopsy
Number of subjects: 265
Study: 32176342

Group type: EXPERIMENTAL
Intervention: Haptic simulator (Virteasy)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional practical work on plastic analogue teeth (Kavo)
Number of subjects: 88
Study: 36197167

Group type: EXPERIMENTAL
Intervention: Humidified low-flow oxygen therapy
Number of subjects: 213

Group type: COMPARATOR
Intervention: Nonhumidified low-flow oxygen therapy
Number of subjects: 213
Study: 33431381

Group type: EXPERIMENTAL
Intervention: PSA testing
Number of subjects: 2808477

Group type: EXPERIMENTAL
Intervention: Opportunistic PSA screening
Number of subjects: 2808477
Study: 32846821

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral acetaminophen
Number of subjects: 0
Study: 33855859

Group type: EXPERIMENTAL
Intervention: Scheduled rumination time
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mindfulness, shaping, and disengagement strategies
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 60
Study: 32502754

Group type: EXPERIMENTAL
Intervention: Woodcast®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delta‐Cast®
Number of subjects: 0

Group type: COMPARATOR
Intervention: OrthoTape
Number of subjects: 0
Study: 34781363

Group type: EXPERIMENTAL
Intervention: Eltrombopag 50 mg daily
Number of subjects: 74

Group type: COMPARATOR
Intervention: IVIG 1 or 2 g/kg
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 74
Study: 33104216

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP)
Number of subjects: 0
Study: 32114905

Group type: EXPERIMENTAL
Intervention: Therapy Component Checklist (TCC)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Self-rating of adherence
Number of subjects: 230
Study: 36401247

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - complex intervention including individual, group, and community actions.
Number of subjects: 3062

Group type: COMPARATOR
Intervention: Control Group (CG) - brief advice during usual doctor visits.
Number of subjects: 3062
Study: 35435472

Group type: EXPERIMENTAL
Intervention: veliparib 400 mg BID
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: veliparib 50-500 mg BID
Number of subjects: 98
Study: 32282591

Group type: EXPERIMENTAL
Intervention: Exteriorization
Number of subjects: 180

Group type: COMPARATOR
Intervention: In situ uterine repair
Number of subjects: 180
Study: 35549686

Group type: COMPARATOR
Intervention: Serum vitamin D3 levels in control males
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Serum vitamin D3 levels in case and control groups
Number of subjects: 252
Study: 34680131

Group type: EXPERIMENTAL
Intervention: Synolis VA
Number of subjects: 96
Study: 32869578

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine rehabilitation training
Number of subjects: 60
Study: 34845555

Group type: EXPERIMENTAL
Intervention: Biliary stent with double-strand 125I seeds radiotherapy drainage tube placement
Number of subjects: 42

Group type: COMPARATOR
Intervention: Biliary stent with common drainage tube implantation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 32453667

Group type: EXPERIMENTAL
Intervention: Augmented aUCL repair with internal bracing
Number of subjects: 16

Group type: COMPARATOR
Intervention: Modified docking technique (control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reconstruction techniques
Number of subjects: 16
Study: 34273052

Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (eAT), N = 165
Number of subjects: 323

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC), N = 158
Number of subjects: 323
Study: 34682399

Group type: EXPERIMENTAL
Intervention: Local ischemic preconditioning (LIPC)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham (SHAM)
Number of subjects: 15
Study: 34133971

Group type: EXPERIMENTAL
Intervention: End-of-life training intervention (4 small-group 4-hour educational sessions)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: End-of-life training intervention
Number of subjects: 324
Study: 32601460

Group type: EXPERIMENTAL
Intervention: Intervention targeting perceptions of social norms regarding pro-diversity attitudes
Number of subjects: 2490
Study: 33859125

Group type: EXPERIMENTAL
Intervention: Cannabis, cannabis-derived products, and synthetic cannabinoids
Number of subjects: 1
Study: 34196106

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - 3 × 5 min administration of 200 mmHg sphygmomanometer on the arm (n=31)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham treatment (n=29)
Number of subjects: 60
Study: 33152965

Group type: COMPARATOR
Intervention: Fentanyl 1–2 μg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fentanyl 6–7 μg/kg
Number of subjects: 60
Study: 36052684

Group type: EXPERIMENTAL
Intervention: CCB+thiazide
Number of subjects: 405

Group type: COMPARATOR
Intervention: ACE-inhibitor+thiazide
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: CCB+ACE-inhibitor
Number of subjects: 405
Study: 32997791

Group type: EXPERIMENTAL
Intervention: Ultrafast ultrasound following cervical magnetic stimulation (CMS)
Number of subjects: 13
Study: 35482348

Group type: EXPERIMENTAL
Intervention: Primary RT (60 Gy of RT with concurrent weekly cisplatin in node-positive patients)
Number of subjects: 61

Group type: COMPARATOR
Intervention: TOS and neck dissection (ND) with adjuvant reduced-dose RT depending on pathologic findings
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Primary RT
Number of subjects: 61

Group type: COMPARATOR
Intervention: TOS and ND
Number of subjects: 61
Study: 32252643

Group type: EXPERIMENTAL
Intervention: Classification-based biopsychosocial approach to LBP management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biopsychosocially-oriented patient education booklet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based care strategies
Number of subjects: 0
Study: 32673552

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 34488362

Group type: EXPERIMENTAL
Intervention: Combined treatment group (CT) - TESSYS technique under spinal endoscopy + drug therapy (coenzyme A, adenosine triphosphate, 10% glucose injection, 10% potassium chloride, vitamin B6, vitamin B12, dexamethasone, 20% mannitol, traditional Chinese medicine)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Combined treatment group (CT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Single operation group (SO)
Number of subjects: 140
Study: 35943003

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neurofeedback combined with Vitamin D
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study: 33561312

Group type: EXPERIMENTAL
Intervention: Panitumumab 6 mg/kg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Bevacizumab 10 mg/kg
Number of subjects: 88
Study: 32732500

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No TXA (Control)
Number of subjects: 15
Study: 36074560

Group type: EXPERIMENTAL
Intervention: Achieving Self‐directed Integrated Cancer Aftercare (ASICA)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 240
Study: 33106183

Group type: EXPERIMENTAL
Intervention: High dose Interferon beta-1a + lopinavir/ritonavir (Kaletra)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Low dose Interferon beta-1a + lopinavir/ritonavir (Kaletra)
Number of subjects: 100
Study: 33596972

Group type: EXPERIMENTAL
Intervention: Computer-based alcohol reduction intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard-of-care control condition
Number of subjects: 200
Study: 32339169

Group type: EXPERIMENTAL
Intervention: Capacitive resistive radiofrequency therapy (RF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no RF)
Number of subjects: 60
Study: 35395957

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine, twice daily for 14 days
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir, twice daily for 14 days
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo, twice daily for 14 days
Number of subjects: 300
Study: 34082801

Group type: EXPERIMENTAL
Intervention: Sweet manioc starch (SMS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Uncooked cornstarch (UCCS)
Number of subjects: 11
Study: 32787925

Group type: EXPERIMENTAL
Intervention: Directly observed therapy (DOT)
Number of subjects: 1656

Group type: EXPERIMENTAL
Intervention: Self-administered therapy (SAT)
Number of subjects: 1656

Group type: EXPERIMENTAL
Intervention: Informed patient choice of either DOT or SAT
Number of subjects: 1656

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of three strategies for delivering 3HP
Number of subjects: 1656
Study: 36271391

Group type: EXPERIMENTAL
Intervention: Aqua Stretch
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aqua Pilates
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (routine drug treatment: NSAIDs & Anti TNF)
Number of subjects: 40
Study: 33236188

Group type: EXPERIMENTAL
Intervention: Facial recognition technology (Noldus FaceReader 7)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5-point Sjövall hedonic scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5-point TASTY hedonic scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3-point TASTY hedonic scale
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hedonic scales (5-point and 3-point)
Number of subjects: 12
Study: 32423348

Group type: COMPARATOR
Intervention: Fruit-and-vegetable diet
Number of subjects: 326

Group type: COMPARATOR
Intervention: DASH diet
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Control diet
Number of subjects: 326
Study: 35979048

Group type: EXPERIMENTAL
Intervention: Positive psychological intervention based on PERMA model
Number of subjects: 120
Study: 33515503

Group type: EXPERIMENTAL
Intervention: Rucaparib 600 mg twice a day orally for six cycles of 28 days or until disease progression, unacceptable toxicity, withdrawal of consent, or death.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 26
Study: 35059823

Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement of dorsal capsule injuries during primary surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: No debridement of dorsal capsule injuries during primary surgery
Number of subjects: 42
Study: 34059327

Group type: EXPERIMENTAL
Intervention: Mirogabalin 10 mg BID
Number of subjects: 1587

Group type: EXPERIMENTAL
Intervention: Mirogabalin 15 mg BID
Number of subjects: 1587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1587
Study: 32576202

Group type: EXPERIMENTAL
Intervention: Integrated cancer screening and prevention clinical decision support (CDS) and shared decision-making tools (SDMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted SDMT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cancer prevention CDS
Number of subjects: 0
Study: 33779532

Group type: EXPERIMENTAL
Intervention: Teacher violence
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Internalizing problems
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Externalizing problems
Number of subjects: 643
Study: 33572546

Group type: EXPERIMENTAL
Intervention: Bevacizumab (5 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34402995

Group type: EXPERIMENTAL
Intervention: SPARK Child Mentoring program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (students who did not receive the intervention)
Number of subjects: 94
Study: 32196954

Group type: EXPERIMENTAL
Intervention: Levocetirizine oral disintegrating tablet (ODT) 5 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Levocetirizine immediate-release tablet (IRT) 5 mg
Number of subjects: 72
Study: 35872697

Group type: EXPERIMENTAL
Intervention: Metformin plus intensive exercise diet therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metformin (control group)
Number of subjects: 120
Study: 32061833

Group type: EXPERIMENTAL
Intervention: Caregiver‐oncologist therapeutic alliance (The Human Connection scale, modified into five items)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Caregiver anxiety (Generalized Anxiety Disorder‐7)
Number of subjects: 97
Study: 36544634

Group type: EXPERIMENTAL
Intervention: ACP gel
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 200
Study: 34853107

Group type: EXPERIMENTAL
Intervention: Care by a CCP physician who serves as a PCP across both inpatient and outpatient settings
Number of subjects: 24

Group type: COMPARATOR
Intervention: Care by a PCP as outpatient and by hospitalists as inpatients (standard care)
Number of subjects: 24
Study: 33745372

Group type: EXPERIMENTAL
Intervention: Neuroanimation therapy (NAT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Conventional occupational therapy (COT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Neuroanimation therapy (NAT) and Conventional occupational therapy (COT) combined
Number of subjects: 24
Study: 33122315

Group type: EXPERIMENTAL
Intervention: Periconceptional surveillance and biomarker survey for anaemia and micronutrient deficiencies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Periconceptional surveillance
Number of subjects: 0
Study: 35421224

Group type: EXPERIMENTAL
Intervention: Gain version of the BART
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Loss version of the BART
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Total performance on the BART
Number of subjects: 254
Study: 35752521

Group type: EXPERIMENTAL
Intervention: Tranexamic acid with phenylephrine and lidocaine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Phenylephrine and lidocaine
Number of subjects: 240
Study: 34346137

Group type: EXPERIMENTAL
Intervention: Combined metformin and clomiphene citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparoscopic ovarian diathermy
Number of subjects: 0
Study: 35357753

Group type: EXPERIMENTAL
Intervention: 30% metformin cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triple combination cream (Kligman's formula)
Number of subjects: 40